Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Smooth muscle potassium channels are a functionally diverse superfamily of ion channels that allow potassium ions to move across the cell membrane in smooth muscle cells. This movement generates an outward current that hyperpolarizes the cell membrane, reduces smooth muscle excitability, and leads to muscle relaxation. In smooth muscle, the major potassium channels include voltage-gated (Kv, notably Kv7/KCNQ), large-conductance calcium-activated (BKCa/Slo1), ATP-sensitive (KATP), and inward-rectifier (Kir) channels. These channels regulate vascular, airway, bladder, and uterine tone. Faulty or dysregulated potassium channel function contributes to diseases such as hypertension, asthma, and bladder instability. Several approved or experimental drugs target these potassium channels to modulate smooth muscle physiology in the treatment of cardiovascular, respiratory, and urinary disorders
Channel openers induce hyperpolarization and smooth muscle relaxation; channel blockers cause depolarization, increased intracellular calcium, and contraction
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smooth muscle potassium channel.